Market Research Logo

EMEA (Europe, Middle East and Africa) Tuberculosis Diagnostics Market Report 2018

EMEA (Europe, Middle East and Africa) Tuberculosis Diagnostics Market Report 2018

This report studies the Tuberculosis Diagnostics market status and outlook of EMEA (Europe, Middle East and Africa) and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in EMEA (Europe, Middle East and Africa), and splits the Tuberculosis Diagnostics market by product type and applications/end industries.

In the last several years, EMEA market of Tuberculosis Diagnostics developed smoothly, with an average growth rate of 4.59%. In 2017, EMEA revenue of Tuberculosis Diagnostics is nearly 854 M USD.

The major players in EMEA (Europe, Middle East and Africa) Tuberculosis Diagnostics market include
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Epistem
Akonni Biosystems
Creative Diagnostics


Geographically, this report is segmented into several key regions, with revenue, market share (%) and growth rate (%) of Tuberculosis Diagnostics in these regions, from 2013 to 2025 (forecast), covering
Europe covers Germany, France, UK, Russia, Italy and Benelux;
Middle East includes Saudi Arabia, Israel, UAE and Iran;
Africa includes South Africa, Nigeria, Egypt and Algeria.

On the basis of product, the Tuberculosis Diagnostics market is primarily split into
Culture-based
Sputum Smear Microscopy
Rapid Molecular
Others

On the basis on the end users/applications, this report covers
Hospital
Diagnostic Laboratories
Others


1 Tuberculosis Diagnostics Overview
1.1 Product Overview and Scope of Tuberculosis Diagnostics
1.2 Classification of Tuberculosis Diagnostics by Product Category
1.2.1 EMEA Tuberculosis Diagnostics Revenue Comparison by Types (2013-2025)
1.2.2 EMEA Tuberculosis Diagnostics Revenue Market Share by Types in 2017
1.2.3 Culture-based Diagnostics
1.2.4 Sputum Smear Microscopy Diagnostics
1.2.5 Rapid Molecular Diagnostics
1.3 EMEA Tuberculosis Diagnostics Market by Applications/End Users
1.4 EMEA Tuberculosis Diagnostics Market Overview by Regions
1.4.1 EMEA Tuberculosis Diagnostics Revenue Comparison by Regions (2013-2025)
1.4.2 Europe Tuberculosis Diagnostics Status and Prospect (2013-2025)
1.4.3 Middle East Tuberculosis Diagnostics Status and Prospect (2013-2025)
1.4.4 Africa Tuberculosis Diagnostics Status and Prospect (2013-2025)
1.5 EMEA Market Size (Profit and Revenue) of Tuberculosis Diagnostics (2013-2025)
1.5.1 EMEA Tuberculosis Diagnostics Profit and Growth Rate (%) (2013-2025)
1.5.2 EMEA Tuberculosis Diagnostics Revenue and Growth Rate (2013-2025)
2 EMEA Tuberculosis Diagnostics Competition by Manufacturers/Players/Suppliers, Regions, Type and Application
2.1 EMEA Tuberculosis Diagnostics Market Competition by Players/ Manufacturers
2.1.1 EMEA Tuberculosis Diagnostics Revenue and Market Share of Major Players (2017-2018)
2.1.2 EMEA Tuberculosis Diagnostics Profit and Market Share (%) by Players (2017-2018)
2.1.3 EMEA Tuberculosis Diagnostics Gross Margin by Players (2017-2018)
2.2 EMEA Tuberculosis Diagnostics Revenue by Type/Product Category
2.3 EMEA Tuberculosis Diagnostics (Value) by Application
2.4 EMEA Tuberculosis Diagnostics Revenue by Regions
2.4.1 EMEA Tuberculosis Diagnostics Profit and Market Share by Regions (2013-2018)
2.4.2 EMEA Tuberculosis Diagnostics Revenue and Market Share by Regions (2013-2018)
2.4.3 EMEA Tuberculosis Diagnostics Gross Margin by Regions (2013-2018)
3 Europe Tuberculosis Diagnostics (Revenue), Countries, Type and Application
3.1 Europe Tuberculosis Diagnostics Profit and Revenue (2013-2018)
3.1.1 Europe Tuberculosis Diagnostics Profit and Growth Rate (2013-2018)
3.1.2 Europe Tuberculosis Diagnostics Revenue and Growth Rate (2013-2018)
3.2 Europe Tuberculosis Diagnostics Revenue and Market Share by Type
3.3 Europe Tuberculosis Diagnostics Revenue and Market Share by Applications
3.4 Europe Tuberculosis Diagnostics Revenue by Countries
3.4.1 Europe Tuberculosis Diagnostics Revenue by Countries (2013-2018)
3.4.2 Germany Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
3.4.3 France Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
3.4.4 UK Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
3.4.5 Russia Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
3.4.6 Italy Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
3.4.7 Benelux Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
4 Middle East Tuberculosis Diagnostics (Revenue), Countries, Type and Application
4.1 Middle East Tuberculosis Diagnostics Revenue (2013-2018)
4.1.1 Middle East Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
4.1.2 Middle East Tuberculosis Diagnostics Revenue and Growth Rate (2013-2018)
4.2 Middle East Tuberculosis Diagnostics Revenue Market Share by Type
4.3 Middle East Tuberculosis Diagnostics Revenue and Market Share by Applications
4.4 Middle East Tuberculosis Diagnostics Revenue by Countries (2013-2018)
4.4.1 Middle East Tuberculosis Diagnostics Revenue by Countries (2013-2018)
4.4.2 Saudi Arabia Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
4.4.3 Israel Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
4.4.4 UAE Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
4.4.5 Iran Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
5 Africa Tuberculosis Diagnostics (Revenue), Countries, Type and Application
5.1 Africa Tuberculosis Diagnostics Revenue (2013-2018)
5.1.1 Africa Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
5.1.2 Africa Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
5.2 Africa Tuberculosis Diagnostics Revenue Market Share by Type
5.3 Africa Tuberculosis Diagnostics Revenue and Market Share by Applications
5.4 Africa Tuberculosis Diagnostics Revenue by Countries (2013-2018)
5.4.1 Africa Tuberculosis Diagnostics Revenue by Countries (2013-2018)
5.4.2 South Africa Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
5.4.3 Nigeria Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
5.4.4 Egypt Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
5.4.5 Algeria Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
6 Analysis of Tuberculosis Diagnostics Industry Key Manufacturers
6.1 Danaher
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Revenue, Cost, Profit, and Gross Margin
6.2 Roche
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Revenue, Cost, Profit, and Gross Margin
6.3 Thermo Fisher Scientific
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Revenue, Cost, Profit, and Gross Margin
6.4 BD
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Revenue, Cost, Profit, and Gross Margin
6.5 Abbott
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Revenue, Cost, Profit, and Gross Margin
6.6 Hologic
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Revenue, Cost, Profit, and Gross Margin
6.7 Qiagen
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Revenue, Cost, Profit, and Gross Margin
6.8 BioMerieux
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Revenue, Cost, Profit, and Gross Margin
6.9 Hain Lifescience
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Revenue, Cost, Profit, and Gross Margin
6.10 Oxford Immunotec
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Revenue, Cost, Profit, and Gross Margin
6.11 Epistem
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Revenue, Cost, Profit, and Gross Margin
6.12 Akonni Biosystems
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 Revenue, Cost, Profit, and Gross Margin
6.13 Creative Diagnostics
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 Revenue, Cost, Profit, and Gross Margin
7 Tuberculosis Diagnostics Manufacturing Cost Analysis
7.1 Tuberculosis Diagnostics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Other Costs Analysis
7.2.3.1 USA Cost of Electricity Analysis
7.2.3.2 USA Water Cost Analysis
7.2.3.3 Europe Cost of Electricity Analysis
7.2.3.4 Europe Water Cost Analysis
7.2.3.5 China Cost of Electricity Analysis
7.2.3.6 China Water Cost Analysis
7.2.4 Manufacturing Expenses
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Tuberculosis Diagnostics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Tuberculosis Diagnostics Market Forecast (2019-2025)
11.1 EMEA Tuberculosis Diagnostics Profit, Revenue Forecast (2019-2025)
11.1.1 EMEA Tuberculosis Diagnostics Profit and Growth Rate Forecast (2019-2025)
11.1.2 EMEA Tuberculosis Diagnostics Revenue and Growth Rate Forecast (2019-2025)
11.2 EMEA Tuberculosis Diagnostics Revenue and Growth Rate Forecast by Regions (2019-2025)
11.3 Europe Tuberculosis Diagnostics Revenue and Growth Rate (%) Forecast by Regions (2019-2025)
11.4 Middle East Tuberculosis Diagnostics Revenue and Growth Rate Forecast by Regions (2019-2025)
11.5 Africa Tuberculosis Diagnostics Revenue and Growth Rate Forecast by Regions (2019-2025)
11.6 EMEA Tuberculosis Diagnostics Revenue by Type (2019-2025)
11.7 EMEA Tuberculosis Diagnostics Revenue Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Tuberculosis Diagnostics Technology
Table EMEA Tuberculosis Diagnostics Comparison by Types
Table EMEA Tuberculosis Diagnostics Revenue (M USD) Market Split by Product Type
Figure EMEA Tuberculosis Diagnostics Revenue Market Share (%) by Types in 2017
Figure Culture-based Diagnostics Product Picture
Figure Sputum Smear Microscopy Diagnostics Product Picture
Figure Rapid Molecular Diagnostics Product Picture
Table EMEA Tuberculosis Diagnostics Revenue (M USD) by Application (2019-2025)
Figure EMEA Revenue Market Share (%) of Tuberculosis Diagnostics by Applications in 2017
Table EMEA Market Tuberculosis Diagnostics Revenue (M USD) Comparison by Regions 2013-2025
Figure Europe Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (2013-2025)
Figure Middle East Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (2013-2025)
Figure Africa Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (2013-2025)
Figure EMEA Tuberculosis Diagnostics Profit (M USD) and Growth Rate (%) (2013-2025)
Figure EMEA Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (2013-2025)
Table EMEA Tuberculosis Diagnostics Revenue (M USD) of Major Players (2017-2018)
Table EMEA Tuberculosis Diagnostics Revenue Market Share (%) by Players (2017-2018)
Figure 2018 Tuberculosis Diagnostics Revenue Market Share (%) by Players
Figure 2017 Tuberculosis Diagnostics Revenue Market Share (%) by Players
Table EMEA Tuberculosis Diagnostics Profit (M USD) by Players (2017-2018)
Table 2018 EMEA Tuberculosis Diagnostics Profit Market Share (%) by Players
Table 2017 EMEA Tuberculosis Diagnostics Profit Market Share (%) by Players
Table EMEA Tuberculosis Diagnostics Gross Margin by Players (2017-2018)
Table EMEA Tuberculosis Diagnostics Revenue (M USD) and Market Share (%) by Type (2013-2018)
Table EMEA Tuberculosis Diagnostics Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share (%) of Tuberculosis Diagnostics by Type in 2013-2018
Table EMEA Tuberculosis Diagnostics Revenue (M USD) and Market Share (%) by Application (2013-2018)
Table EMEA Tuberculosis Diagnostics Revenue Market Share (%) by Application (2013-2018)
Figure Revenue Market Share (%) of Tuberculosis Diagnostics by Application (2013-2018)
Figure EMEA Tuberculosis Diagnostics Revenue Market Share (%) by Application in 2017
Table EMEA Tuberculosis Diagnostics Profit (M USD) and Market Share (%) by Regions (2013-2018)
Table EMEA Tuberculosis Diagnostics Profit Market Share (%) by Regions (2013-2018)
Figure Profit Market Share (%) of Tuberculosis Diagnostics by Regions (2013-2018)
Figure EMEA Tuberculosis Diagnostics Profit Market Share (%) in 2017
Table EMEA Tuberculosis Diagnostics Revenue (M USD) and Market Share (%) by Regions (2013-2018)
Table EMEA Tuberculosis Diagnostics Revenue Market Share (%) by Regions (2013-2018)
Figure Revenue Market Share (%) of Tuberculosis Diagnostics by Regions (2013-2018)
Figure EMEA Tuberculosis Diagnostics Revenue Market Share (%) Regions in 2017
Table EMEA Tuberculosis Diagnostics Gross Margin by Regions (2013-2018)
Figure Europe Tuberculosis Diagnostics Profit (M USD) and Growth Rate (%) (2013-2018)
Figure Europe Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Table Europe Tuberculosis Diagnostics Revenue (M USD) by Type (2013-2018)
Table Europe Tuberculosis Diagnostics Revenue Market Share (%) by Type (2013-2018)
Figure Europe Tuberculosis Diagnostics Revenue Market Share (%) by Type in 2017
Table Europe Tuberculosis Diagnostics Revenue (M USD) by Applications (2013-2018)
Table Europe Tuberculosis Diagnostics Market Share (%) by Applications (2013-2018)
Figure Europe Tuberculosis Diagnostics Market Share (%) by Applications in 2017
Table Europe Tuberculosis Diagnostics Revenue (M USD) by Countries (2013-2018)
Table Europe Tuberculosis Diagnostics Revenue Market Share (%) by Countries (2013-2018)
Figure Europe Tuberculosis Diagnostics Revenue Market Share (%) by Countries (2013-2018)
Figure Europe Tuberculosis Diagnostics Revenue Market Share (%) by Countries in 2017
Figure Germany Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure France Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure UK Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Russia Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Italy Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Benelux Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Middle East Tuberculosis Diagnostics Revenue and Growth Rate (%) (2013-2018)
Figure Middle East Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Table Middle East Tuberculosis Diagnostics Revenue (M USD) by Type (2013-2018)
Table Middle East Tuberculosis Diagnostics Market Share (%) by Type (2013-2018)
Figure Middle East Tuberculosis Diagnostics Market Share (%) by Type in 2017
Table Middle East Tuberculosis Diagnostics Revenue (M USD) by Applications (2013-2018)
Table Middle East Tuberculosis Diagnostics Market Share (%) by Applications (2013-2018)
Figure Middle East Tuberculosis Diagnostics Revenue Market Share (%) by Application in 2017
Table Middle East Tuberculosis Diagnostics Revenue (M USD) by Countries (2013-2018)
Table Middle East Tuberculosis Diagnostics Revenue Market Share (%) by Countries (2013-2018)
Figure Middle East Tuberculosis Diagnostics Revenue Market Share (%) by Countries in (2013-2018)
Figure Middle East Tuberculosis Diagnostics Revenue Market Share (%) by Countries in 2017
Figure Saudi Arabia Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Israel Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure UAE Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Iran Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Africa Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Africa Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (2013-2018)
Table Africa Tuberculosis Diagnostics Revenue (M USD) by Type (2013-2018)
Table Africa Tuberculosis Diagnostics Revenue Market Share (%) by Type (2013-2018)
Figure Africa Tuberculosis Diagnostics Revenue Market Share (%) by Type in 2017
Table Africa Tuberculosis Diagnostics Revenue (M USD) by Applications (2013-2018)
Table Africa Tuberculosis Diagnostics Revenue Market Share (%) by Applications (2013-2018)
Figure Africa Tuberculosis Diagnostics Revenue Market Share (%) by Applications in 2017
Table Africa Tuberculosis Diagnostics Revenue (M USD) by Countries (2013-2018)
Table Africa Tuberculosis Diagnostics Revenue Market Share (%) by Countries (2013-2018)
Figure Africa Tuberculosis Diagnostics Revenue Market Share (%) by Countries (2013-2018)
Figure Africa Tuberculosis Diagnostics Revenue Market Share (%) by Countries in 2017
Figure South Africa Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Nigeria Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Egypt Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Figure Algeria Tuberculosis Diagnostics Revenue (M USD) and Growth Rate (%) (2013-2018)
Table Danaher Company Profile
Figure Tuberculosis Diagnostics Product Information of Danaher
Table Tuberculosis Diagnostics Revenue (M USD), Profit (M USD), Cost (M USD) and Gross Margin of Danaher (2017 and 2018)
Table Roche Company Profile
Figure Tuberculosis Diagnostics Product Information of Roche
Table Tuberculosis Diagnostics Revenue (M USD), Profit (M USD), Cost (M USD) and Gross Margin of Roche (2017 and 2018)
Table Thermo Fisher Scientific Company Profile
Figure Tuberculosis Diagnostics Product Information of Thermo Fisher Scientific
Table Tuberculosis Diagnostics Revenue (M USD), Profit (M USD), Cost (M USD) and Gross Margin of Thermo Fisher Scientific (2017 and 2018)
Table BD Company Profile
Figure Tuberculosis Diagnostics Product Information of BD
Table Tuberculosis Diagnostics Revenue (M USD), Profit (M USD), Cost (M USD) and Gross Margin of BD (2017 and 2018)
Table Abbott Company Profile
Figure Tuberculosis Diagnostics Product Information of Abbott
Table Tuberculosis Diagnostics Revenue (M USD), Profit (M USD), Cost (M USD) and Gross Margin of Abbott (2017 and 2018)
Table Hologic Company Profile
Figure Tuberculosis Diagnostics Product Information of Hologic
Table Tuberculosis Diagnostics Revenue (M USD), Profit (M USD), Cost (M USD) and Gross Margin of Hologic (2017 and 2018)
Table Qiagen Company Profile
Figure Tuberculosis Diagnostics Product Information of Qiagen
Table Tuberculosis Diagnostics Revenue (M USD), Profit (M USD), Cost (M USD) and Gross Margin of Qiagen (2017 and 2018)
Table BioMerieux Company Profile

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report